دورية أكاديمية
Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method.
| العنوان: | Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. |
|---|---|
| المؤلفون: | Davidović M; Graduate School of Health Sciences, University of Bern, Bern, Switzerland.; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland., Asangbeh SL; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Taghavi K; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Dhokotera T; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Jaquet A; University of Bordeaux, National Institute for Health and Medical Research (INSERM), UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France., Musick B; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN., Van Schalkwyk C; The South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa., Schwappach D; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Rohner E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Murenzi G; Einstein-Rwanda Research and Capacity Building Program, Research for Development (RD Rwanda) and Rwanda Military Hospital, Kigali, Rwanda., Wools-Kaloustian K; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN., Anastos K; Departments of Medicine and Epidemiology, Albert Einstein College of Medicine, Bronx, NY., Omenge OE; Department of Reproductive Health, Moi University School of Medicine, Eldoret, Kenya., Boni SP; Programme PAC-CI, Abidjan, Côte d'Ivoire.; National Cancer Control Program, Côte d'Ivoire; and., Duda SN; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN., von Groote P; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Bohlius J; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. |
| مؤلفون مشاركون: | International Epidemiology Databases to Evaluate AIDS |
| المصدر: | Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Feb 01; Vol. 95 (2), pp. 170-178. |
| نوع المنشور: | Review; Journal Article; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins, Inc., c1999- |
| مواضيع طبية MeSH: | HIV Infections*/diagnosis , HIV Infections*/drug therapy , HIV Infections*/prevention & control , Uterine Cervical Neoplasms*/diagnosis , Uterine Cervical Neoplasms*/prevention & control, Humans ; Female ; Consensus ; Delphi Technique ; Africa South of the Sahara/epidemiology |
| مستخلص: | Background: Of women with cervical cancer (CC) and HIV, 85% live in sub-Saharan Africa, where 21% of all CC cases are attributable to HIV infection. We aimed to generate internationally acceptable facility-based indicators to monitor and guide scale up of CC prevention and care services offered on-site or off-site by HIV clinics. Methods: We reviewed the literature and extracted relevant indicators, grouping them into domains along the CC control continuum. From February 2021 to March 2022, we conducted a three-round, online Delphi process to reach consensus on indicators. We invited 106 experts to participate. Through an anonymous, iterative process, participants adapted the indicators to their context (round 1), then rated them for 5 criteria on a 5-point Likert-type scale (rounds 2 and 3) and then ranked their importance (round 3). Results: We reviewed 39 policies from 21 African countries and 7 from international organizations; 72 experts from 15 sub-Saharan Africa countries or international organizations participated in our Delphi process. Response rates were 34% in round 1, 40% in round 2, and 44% in round 3. Experts reached consensus for 17 indicators in the following domains: primary prevention (human papillomavirus prevention, n = 2), secondary prevention (screening, triage, treatment of precancerous lesions, n = 11), tertiary prevention (CC diagnosis and care, n = 2), and long-term impact of the program and linkage to HIV service (n = 2). Conclusion: We recommend that HIV clinics that offer CC control services in sub-Saharan Africa implement the 17 indicators stepwise and adapt them to context to improve monitoring along the CC control cascade. Competing Interests: S.L.A. received the Swiss Government Excellence Scholarship, No 2019.0741. The remaining authors have no funding or conflicts of interest to disclose. (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.) |
| References: | Palliat Med. 2017 Sep;31(8):684-706. (PMID: 28190381) Lancet Glob Health. 2021 Feb;9(2):e161-e169. (PMID: 33212031) J Int AIDS Soc. 2020 Jun;23 Suppl 1:e25508. (PMID: 32562370) BMJ Open. 2020 May 15;10(5):e035246. (PMID: 32414825) J Low Genit Tract Dis. 2016 Jan;20(1):31-7. (PMID: 26579842) J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):195-205. (PMID: 29916959) J Clin Epidemiol. 2019 Apr;108:110-120. (PMID: 30557677) BMJ. 1995 Aug 5;311(7001):376-80. (PMID: 7640549) AIDS. 2018 Mar 27;32(6):795-808. (PMID: 29369827) BMC Public Health. 2012 Mar 23;12:237. (PMID: 22443255) Int J Cancer. 2016 Aug 15;139(4):908-15. (PMID: 27006131) J Int AIDS Soc. 2015 Dec 01;18(Suppl 5):20282. (PMID: 26643456) BMC Public Health. 2022 Aug 10;22(1):1530. (PMID: 35948944) Glob Health Sci Pract. 2018 Jun 29;6(2):288-298. (PMID: 29959272) Int J Gynaecol Obstet. 2021 Jan;152(1):53-59. (PMID: 33188707) PLoS One. 2017 Jul 21;12(7):e0181156. (PMID: 28732037) J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S17-26. (PMID: 25117957) EClinicalMedicine. 2022 Nov 17;54:101754. (PMID: 36583170) Front Med (Lausanne). 2022 Sep 15;9:930462. (PMID: 36186820) Int J Cancer. 2022 Mar 1;150(5):761-772. (PMID: 34626498) J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S322-S331. (PMID: 31764270) Int J Gynaecol Obstet. 2019 Nov;147(2):246-251. (PMID: 31482577) PLoS One. 2011;6(6):e20476. (PMID: 21694759) J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S87-95. (PMID: 25117965) PLOS Glob Public Health. 2022;2(2):. (PMID: 36860760) MethodsX. 2021 May 28;8:101401. (PMID: 34430297) J Int AIDS Soc. 2022 Oct;25(10):e26021. (PMID: 36225139) Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:33-40. (PMID: 28691330) J Clin Epidemiol. 2014 Apr;67(4):401-9. (PMID: 24581294) |
| معلومات مُعتمدة: | Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States DK NIDDK NIH HHS; U01 AI096299 United States AI NIAID NIH HHS; U01 AI069923 United States AI NIAID NIH HHS; R24 AI124872 United States AI NIAID NIH HHS; U01 AI069911 United States AI NIAID NIH HHS; Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States TW FIC NIH HHS; U01 AI069919 United States AI NIAID NIH HHS; U01 AI069907 United States AI NIAID NIH HHS; U01 AI069924 United States AI NIAID NIH HHS; Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States HL NHLBI NIH HHS; Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States MH NIMH NIH HHS; Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States DA NIDA NIH HHS; U01 AI069918 United States AI NIAID NIH HHS; Central Africa, U01AI096299; East Africa, U01AI069911; Southern Africa, U01AI069924; West Africa, U01AI069919 United States AA NIAAA NIH HHS |
| تواريخ الأحداث: | Date Created: 20240111 Date Completed: 20240115 Latest Revision: 20240312 |
| رمز التحديث: | 20240312 |
| مُعرف محوري في PubMed: | PMC10794028 |
| DOI: | 10.1097/QAI.0000000000003343 |
| PMID: | 38211958 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1944-7884 |
|---|---|
| DOI: | 10.1097/QAI.0000000000003343 |